| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
Delaware |
94-3015807 |
|
(State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
|
|
|
|
965 Atlantic Avenue, Alameda, California |
94501 |
|
(Address of principal executive offices) |
(Zip Code) |
|
| ||
|
| ||
| Item 1. | Financial Statements | Page | |
| Condensed Consolidated Balance Sheets at September 30, 2004 and December 31, 2003 | 1 | ||
| Condensed Consolidated Statements of Operations For the three and nine months ended September 30, 2004 | 2 | ||
| Condensed Consolidated Statements of Cash Flows For the nine months ended September 30, 2004 and 2003 | 3 | ||
| Notes to Condensed Consolidated Financial Statements | 4 | ||
| Item 2. | Managements Discussion and Analysis of Financial Condition and Results of Operations | 8 | |
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 25 | |
| Item 4. | Controls and Procedures | 25 | |
| PART II. OTHER INFORMATION | |||
| Item 1. | Legal Proceedings | 26 | |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 26 | |
| Item 3. | Defaults Upon Senior Securities | 26 | |
| Item 4. | Submission of Matters to a Vote of Security Holders | 26 | |
| Item 5. | Other Information | 27 | |
| Item 6. | Exhibits | 27 | |
| Signatures | 27 | ||
|
| ||
|
| ||
| (in thousands, except share and per share amounts) |
September 30, 2004 |
December 31, 2003 |
|||||
|
|
|||||||
|
Assets |
|||||||
|
Current assets: |
|||||||
|
Cash and cash equivalents |
$ |
7,860 |
$ |
1,045 |
|||
|
Inventories, net |
18 |
19 |
|||||
|
Prepaid expenses and other current assets |
63 |
91 |
|||||
|
Total current assets |
7,941 |
1,155 |
|||||
|
Property and equipment, at cost: |
|||||||
|
Laboratory and other equipment |
354 |
837 |
|||||
|
Leasehold improvements |
73 |
73 |
|||||
|
Furniture and fixtures |
- |
3 |
|||||
|
427 |
913 |
||||||
|
Accumulated depreciation |
319 |
664 |
|||||
|
108 |
249 |
||||||
|
Deferred debt issuance cost |
- |
1 |
|||||
|
Total assets |
$ |
8,049 |
$ |
1,405 |
|||
|
Liabilities and stockholders' equity (deficit) |
|||||||
|
Current liabilities: |
|||||||
|
Short-term notes payable to related parties, unsecured |
$ |
90 |
$ |
326 |
|||
|
Short-term notes payable to related parties, secured |
254 |
682 |
|||||
|
Accounts payable |
357 |
972 |
|||||
|
Accrued liabilities |
477 |
650 |
|||||
|
Accrued compensation and related expense |
156 |
160 |
|||||
|
Deferred gain on sale of assets |
- |
4,616 |
|||||
|
Deferred rent |
74 |
183 |
|||||
|
Total current liabilities |
1,408 |
7,589 |
|||||
|
Convertible note payable (net of beneficial conversion feature of $1 as of December 31, 2003) |
- |
16 |
|||||
|
Total liabilities |
1,408 |
7,605 |
|||||
|
Commitments |
|||||||
|
Stockholders equity (deficit) |
|||||||
|
|
|||||||
|
Common stock, $0.01 par value, 120,000,000 shares authorized; 62,371,069 issued and outstanding at Sept 30, 2004; 29,253,294 issued and outstanding at December 31, 2003 |
624 |
293 |
|||||
|
Additional paid-in capital |
124,365 |
109,437 |
|||||
|
Notes receivable from stockholder |
(187 |
) |
(208 |
) | |||
|
Accumulated deficit |
(118,161 |
) |
(115,722 |
) | |||
|
Stockholders equity (deficit) |
6,641 |
(6,200 |
) | ||||
|
Total liabilities and stockholders' equity (deficit) |
$ |
8,049 |
$ |
1,405 |
|||
|
| ||
| 1 | ||
|
| ||
|
Three months ended Sept. 30, |
Nine months ended Sept.30, |
||||||||||||
|
(in thousands, except per share amounts) |
2004 |
2003 |
2004 |
2003 |
|||||||||
|
| |||||||||||||
|
Revenues |
$ |
49 |
$ |
4 |
$ |
541 |
$ |
8 |
|||||
|
Cost of goods |
3 |
5 |
11 |
17 |
|||||||||
|
Operating expenses: |
|||||||||||||
|
Research and development |
2,605 |
793 |
4,956 |
3,461 |
|||||||||
|
Selling, general and administrative |
781 |
599 |
2,586 |
2,025 |
|||||||||
|
Total |
3,386 |
1,392 |
7,542 |
5,486 |
|||||||||
|
Loss from operations |
(3,340 |
) |
(1,393 |
) |
(7,012 |
) |
(5,495 |
) | |||||
|
Gain on sale of assets |
- |
- |
4,616 |
- |
|||||||||
|
Interest (expense) and other income, net |
- |
(9 |
) |
(43 |
) |
(7 |
) | ||||||
|
Net loss |
(3,340 |
) |
(1,402 |
) |
(2,439 |
) |
(5,502 |
) | |||||
|
Preferred dividends |
- |
(60 |
) |
- |
(161 |
) | |||||||
|
Net loss applicable to common stockholders |
$ |
(3,340 |
) |
$ |
(1,462 |
) |
$ |
(2,439 |
) |
$ |
(5,663 |
) | |
|
Net loss per share applicable to common stockholders, basic and diluted |
$ |
(0.05 |
) |
$ |
(0.06 |
) |
$ |
(0.06 |
) |
$ |
(0.23 |
) | |
|
Shares used to calculate net loss per share applicable: |
|||||||||||||
|
to common stockholders, basic and diluted |
62,371 |
25,137 |
43,667 |
25,136 |
|||||||||
| 2 | ||
|
| ||
|
3 | ||
|
| ||